SLSN vs IPAR vs EL vs SKIN

For growth investors, Solesence, Inc.

Common Stock (SLSN) is the stronger pick with 40. 4% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Inter Parfums, Inc. (IPAR) offers the better valuation at 17. 9x trailing P/E (19. 4x forward), making it the more compelling value choice. Analysts rate Inter Parfums, Inc. (IPAR) a "Hold" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Inter Parfums, Inc.

(IPAR) is the cheapest at 17. 9x versus Solesence, Inc. Common Stock at 18. 6x. On forward P/E, Inter Parfums, Inc. is actually cheaper at 19. 4x.

Over the past 5 years, Inter Parfums, Inc.

(IPAR) delivered a total return of +41. 9%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: IPAR returned +255. 2% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Inter Parfums, Inc.

(IPAR) is the lower-risk stock at 0. 54β versus Solesence, Inc. Common Stock's 2. 02β — meaning SLSN is approximately 272% more volatile than IPAR relative to the S&P 500. On balance sheet safety, Inter Parfums, Inc. (IPAR) carries a lower debt/equity ratio of 20% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Solesence, Inc.

Common Stock (SLSN) is pulling ahead at 40. 4% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: Solesence, Inc. Common Stock grew EPS 179. 0% year-over-year, compared to -391. 7% for The Estée Lauder Companies Inc.. Over a 3-year CAGR, SLSN leads at 21. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Inter Parfums, Inc.

(IPAR) is the more profitable company, earning 11. 3% net margin versus -7. 9% for The Estée Lauder Companies Inc. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IPAR leads at 18. 2% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — EL leads at 73. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Inter Parfums, Inc.

(IPAR) trades at 19. 4x forward P/E versus 38. 4x for The Estée Lauder Companies Inc. — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SKIN: 42. 9% to $1. 30.

In this comparison, IPAR (3.

4% yield), EL (2. 0% yield) pay a dividend. SLSN, SKIN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Inter Parfums, Inc.

(IPAR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 54), 3. 4% yield, +255. 2% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IPAR: +255. 2%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SLSN is a small-cap high-growth stock; IPAR is a small-cap deep-value stock; EL is a mid-cap quality compounder stock; SKIN is a small-cap quality compounder stock. IPAR, EL pay a dividend while SLSN, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.